​
Login / Signup
Xiaoping Pan
ORCID
Publication Activity (10 Years)
Years Active: 2021-2024
Publications (10 Years): 4
Top Topics
Poor Prognosis
Breast Cancer Cells
Gene Expression
Endoplasmic Reticulum Stress
Top Venues
Cancer biotherapy & radiopharmaceuticals
Journal of biochemical and molecular toxicology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Xiaolu Hong
,
Xiaoping Pan
Exosome-Derived MicroRNA-221-3p Desensitizes Breast Cancer Cells to Adriamycin by Regulating PIK3r1 -Mediated Glycose Metabolism.
Cancer biotherapy & radiopharmaceuticals
39 (6) (2024)
Xiaolu Hong
,
Xiaoping Pan
Exosome-Derived MicroRNA-221-3p Desensitizes Breast Cancer Cells to Adriamycin by Regulating PIK3r1 -Mediated Glycose Metabolism.
Cancer biotherapy & radiopharmaceuticals
39 (6) (2024)
Xiaolu Hong
,
Xiaoping Pan
Exosome-Derived MicroRNA-221-3p Desensitizes Breast Cancer Cells to Adriamycin by Regulating PIK3r1 -Mediated Glycose Metabolism.
Cancer biotherapy & radiopharmaceuticals
(2024)
Sumei Li
,
Fengru Jiang
,
Feiyu Chen
,
Yingzhao Deng
,
Xiaoping Pan
Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
Journal of biochemical and molecular toxicology
36 (1) (2021)